Roche melanoma pill spurs growth of other cancers (Reuters)
Reuters – A new study helps explain why up to a third of advanced melanoma patients who take Roche Holding’s pill Zelboraf develop a less deadly form of skin cancer known as cutaneous squamous cell carcinoma, and points to a potential fix.